✦ LIBER ✦

Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study

✍ Scribed by Zi-Yu Li; Lei Tang; Lian-Hai Zhang; Zhao-De Bu; Ai-Wen Wu; Xiao-Jiang Wu; Xiang-Long Zong; Qi Wu; Fei Shan; Shuang-Xi Li; Hui Ren; Xiao-Peng Zhang; Jia-Fu Ji

Book ID: 107577006
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 173 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9381-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study of weekly paclitaxel plus 5-fluo

A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer

✍ Yanhong Gu; Yongqian Shu; Qiang Xu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 187 KB

A multiple-center phase II study of week

A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

✍ Jen-Shi Chen; Yen-Yang Chen; Jen-Sheng Huang; Kun-Yun Yeh; Ping-Tsung Chen; Wen- 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB

A phase II study of weekly docetaxel and

A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

✍ Li, C-P; Chen, J-S; Chen, L-T; Yen, C-J; Lee, K-D; Su, W-P; Lin, P-C; Lu, C-H; T 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

VEGFR-3 and CXCR4 as predictive markers

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

✍ Thomas Thomaidis,Annett Maderer,Salah-Eddin Al-Batran,Janis Kany… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 618 KB

Docetaxel – Cisplatine – 5 Fluorouracile

Docetaxel – Cisplatine – 5 Fluorouracile versus Cisplatine – 5 Fluorouracile en première ligne des cancers métastatiques ou récidivants de l’estomac: E. Van Cutsem, V.M. Moiseyenko, S. Tjulandin, A. Majlis, M. Constenla, C. Boni, A. Rodrigues, M. Fodor, Y. Chao, E. Voznyi, M.L. Risse, J.A. Ajani, V325 Study Group Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006;24:4991-4997

✍ C. Mariette; S. Benoist; Ph. De Mestier 📂 Article 📅 2007 🏛 Masson Editeur 🌐 French ⚖ 86 KB

9091 Activity, safety and compliance of

9091 Activity, safety and compliance of sequential chemotherapy with cisplatin (CDDP) plus oral vinorelbine (VNRos) followed by three-weekly docetaxel (DOC) as first-line treatment for advanced non-small cell lung cancer (NSCLC): a single-centre phase II study

✍ Teragni, C.; Palumbo, R.; Bernardo, A.; Strada, M.R.; Poggi, G.; Amatu, A.; Mont 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB